Literature DB >> 22273243

Using self-regulation theory to examine patient goals, barriers, and facilitators for taking medication.

Suzan N Kucukarslan1, Sheena Thomas, Abraham Bazzi, Deborah Virant-Young.   

Abstract

BACKGROUND: : Self-regulation theory predicts that patient behavior is determined by the patient's assessment of his/her condition (illness presentation) and related health goals. Patients will adapt their behavior to achieve those goals. However, there are multiple levels of goals. In such cases, those lower-level goals (health goals) that are strongly correlated with higher-level goals (i.e. quality of life [QOL]) are more likely to drive patient behavior. Medication non-compliance is a health behavior that challenges healthcare practitioners. Thus, the primary aim of this paper is to explore the relationship between the lower-level goals for taking medication with higher-level goals. This paper also identifies patient-perceived barriers and facilitators toward achieving goals as they may relate to patients' illness representation.
OBJECTIVES: : To identify lower- and higher-level goals associated with medication use for chronic conditions. To determine if there is a relationship between higher-level (global) goals and lower-level (health-related) goals. To identify patient-perceived facilitators and barriers to achieving those goals.
METHODS: : This was a prospective, observational study using a mailed survey. The setting was a US Midwestern state-wide survey. Participants were patients living in the community with hypertension, heart disease, diabetes mellitus, or arthritis, and taking prescription medication for any one of those conditions. The main outcome measures were lower- and higher-level goals related to medication use. The survey asked the participants if they had achieved their goals and to identify factors that may pose as barriers or facilitators to achieving them. Pearson correlation was used to test the relationship between the lower- and higher-level goals at p < 0.05.
RESULTS: : Responses from 292 qualifying patients were obtained. A significant relationship between lower- and higher-level goals existed (p = 0.03). Preventing future health problems was the most important lower-level goal for almost half of the respondents. Approximately 43% of the respondents said 'improving or maintaining quality of life' was their most important higher-level goal. Elderly respondents (65 years or older) said that being able to carry out daily activities on their own was their most important higher-level goal. To achieve this goal, they identified 'preventing future health problems' as the associated lower-level goal. One-third of the respondents stated that they had not yet achieved their medication-related goals. Patients identified good communication with their physicians (35%), the effectiveness of the drug product (32%), and their ability to monitor their condition (20%) as important factors toward helping them achieve their goals. Medication costs (30%), drug adverse effects (25%), and the lack of drug effectiveness (22%) were factors that patients identified as barriers to achieving their goals.
CONCLUSION: : There is a significant and positive relationship between the lower- and higher-level goals. Healthcare providers can work with their patients to achieve their goals. Both good communication with the prescriber and the effectiveness of the drug product were identified as the most important facilitator by one-third of the respondents. Future research should study if relating the impact of good symptom control or the reduction of future health risks to QOL or longevity, as deemed relevant by the patient, influences medication adherence behavior.

Entities:  

Year:  2009        PMID: 22273243     DOI: 10.2165/11313830-000000000-00000

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  15 in total

Review 1.  Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.

Authors:  Gary Harmon; John Lefante; Marie Krousel-Wood
Journal:  Curr Opin Cardiol       Date:  2006-07       Impact factor: 2.161

2.  Development of the purposeful action medication-taking questionnaire.

Authors:  Mary Jayne Johnson; Sandra Rogers
Journal:  West J Nurs Res       Date:  2006-04       Impact factor: 1.967

3.  The problem of non-response in sample surveys.

Authors:  M H HANSEN; W N HURWITZ
Journal:  J Am Stat Assoc       Date:  1946-12       Impact factor: 5.033

Review 4.  Medication decision-making and management: a client-centered model.

Authors:  B Chewning; B Sleath
Journal:  Soc Sci Med       Date:  1996-02       Impact factor: 4.634

5.  Reasons for adherence with antihypertensive medication.

Authors:  S Svensson; K I Kjellgren; J Ahlner; R Säljö
Journal:  Int J Cardiol       Date:  2000 Nov-Dec       Impact factor: 4.164

6.  Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial.

Authors:  K R Lorig; D S Sobel; A L Stewart; B W Brown; A Bandura; P Ritter; V M Gonzalez; D D Laurent; H R Holman
Journal:  Med Care       Date:  1999-01       Impact factor: 2.983

7.  Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour.

Authors:  Molly Byrne; Jane Walsh; Andrew W Murphy
Journal:  J Psychosom Res       Date:  2005-05       Impact factor: 3.006

8.  Cholesterol control, medication adherence and illness cognition.

Authors:  Noel T. Brewer; Gretchen B. Chapman; Susan Brownlee; Elaine A. Leventhal
Journal:  Br J Health Psychol       Date:  2002-11

Review 9.  Medication compliance: the patient's perspective.

Authors:  L S Morris; R M Schulz
Journal:  Clin Ther       Date:  1993 May-Jun       Impact factor: 3.393

Review 10.  Older people and adherence with medication: a review of the literature.

Authors:  Maggi Banning
Journal:  Int J Nurs Stud       Date:  2008-10       Impact factor: 5.837

View more
  3 in total

1.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

Review 2.  Effectiveness of psychological interventions to improve quality of life in people with long-term conditions: rapid systematic review of randomised controlled trials.

Authors:  Niall Anderson; Gozde Ozakinci
Journal:  BMC Psychol       Date:  2018-03-27

3.  Combination of a Self-Regulation Module and Mobile Application to Enhance Treatment Outcome for Patients with Acne.

Authors:  Yi-Shan Liu; Nan-Han Lu; Po-Chuen Shieh; Cheuk-Kwan Sun
Journal:  Medicina (Kaunas)       Date:  2020-06-04       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.